Improving Cochlear Implants to Prevent Tissue Damage
Reduction of Intracochlear Trauma and Fibrosis Using Dual Network, Zwitterionic Hydrogel Thin Films on Cochlear Implant Surfaces
This project is creating special coatings for cochlear implants to help them work better and last longer for people with hearing loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11164833 on NIH RePORTER |
What this research studies
Cochlear implants are vital for many with hearing loss, but the materials used can sometimes cause problems. When the implant is inserted, it can damage any remaining natural hearing, and over time, scar tissue can form around the device. This scar tissue can make the implant less effective by increasing electrical resistance and reducing signal clarity. Our team is developing new, ultra-smooth coatings called zwitterionic hydrogels, which are designed to reduce this initial damage and prevent scar tissue from forming. By applying these durable thin films to existing implant materials, we hope to significantly improve how well cochlear implants work and how safe they are for long-term use.
Who could benefit from this research
Good fit: This research is relevant to individuals who use or are considering cochlear implants for hearing loss.
Not a fit: Patients who do not use or are not candidates for cochlear implants would not directly benefit from this specific materials science research.
Why it matters
Potential benefit: If successful, this could lead to cochlear implants that cause less damage during insertion, preserve more natural hearing, and maintain better function over many years for patients.
How similar studies have performed: Zwitterionic polymers are a new class of materials showing promise in preventing biological fouling, but their application as durable thin films on cochlear implants using this specific photochemical process is a novel approach.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Hansen, Marlan R — University of Iowa
- Study coordinator: Hansen, Marlan R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.